By Carla Mozee, MarketWatch
LONDON (MarketWatch) -- Drug makers took center stage in
European trading Tuesday, with AstraZeneca PLC shares posting their
best advance in nearly three years on news of a potential takeover
bid, and as GlaxoSmithKline PLC climbed on the multibillion-dollar
sales of a business unit.
The Stoxx Europe 600 finished up 1.4% to 337.03 as investors
returned from a four-day Easter holiday break to a slate of
developments in the pharmaceutical sector, the best-performing
group on the pan-European index.
Among the strongest European equity advancers was AstraZeneca ,
with a 4.7% jump in shares following a Daily Telegraph report that
the British drug maker has hired Goldman Sachs and Morgan Stanley
to advise it if Pfizer Inc. (PFE) were to again attempt talks with
the company about a takeover bid. AstraZeneca's share-price rise
was the strongest since August 2011, according to FactSet data.
The Sunday Times of London had earlier reported that Pfizer --
the largest drug maker in the U.S. -- approached AstraZeneca about
a possible merger.
Stock in Novartis AG rose 2.3% as the Swiss company outlined
changes in its portfolio lineup, including plans to buy
GlaxoSmithKline PLC's oncology unit for about $14.5 billion.
Novartis also plans to sell its vaccines unit to Glaxo for $5.25
billion. Glaxo shares climbed 5.2%.
"The loss of the oncology portfolio will raise some eyebrows but
GSK has [been] treading water in this business for a while ... and
its pipeline has not been delivering as strongly as had been
hoped," said Savvas Neophytou, an analyst at Panmure Gordon &
Co., in a note to clients. The size of the oncology-unit deal is
seven times prospective revenue, and "crystalizes significant value
from this business and is a sensible strategic decision," said
Neophytou.
Participating in the rise in drug stocks, Bayer AG picked up 4%,
Hikma Pharmaceuticals PLC latched onto a 5% gain, and Danish firm
Novo Nordisk AS (NVO) kicked higher by 3.7%.
Gains for AstraZeneca and Glaxo helped the U.K.'s FTSE 100 index
rise 0.9% to 6,681.76. Germany's DAX 30 pushed 2% higher to
9,600.09, and France's CAC 40 index advanced 1.2% to 4,484.21.
Outside of deal news, Philips NV (PHG) fell 4.7% after the
company's first-quarter profit fell 14%, and as it spoke of a
"challenging start to the year." Net profit for the diversified
technology group dropped to 138 million euros ($190.5 million) from
EUR161 million in the year-ago period. Revenue fell to EUR5.02
billion from EUR5.26 billion a year ago, hurt by currency
weakness.
Little reaction to Ukraine unrest
Investors appeared to set aside news over the weekend about
further unrest in Ukraine, with five people reportedly shot dead at
a checkpoint near the eastern city of Slavyansk. The shootings came
after the Ukrainian government said it wouldn't battle pro-Russian
protesters who were occupying public buildings during the Easter
holiday. U.S. Vice President Joe Biden in Kiev on Tuesday expressed
support for Ukraine's new government, while the U.S. prepared new
sanctions against Russia.
Heightened uncertainty about Ukraine has driven recent "risk
off" market sentiment, but other, more fundamental "red flags" for
equities -- including a rotation of market leadership, a rally in
bonds this year and flattening of the yield curve, and weakness in
copper and other commodity prices -- don't change the bullish
backdrop for the market, said J.P. Morgan Cazenove in a report
Tuesday. Earnings in the euro zone look likely to grow for the
first time in four years, and the activity backdrop is "robust" in
Europe and in the U.S., it said.
"In our view, equities remain attractively valued vs. other
asset classes, and the inflows are steadily coming through," said
analyst Mislav Matejka in the report, adding that they are "using
dips as an opportunity to add further to Euro recovery plays" such
as euro-zone banks, and value and cyclical stocks.
Data released Tuesday afternoon from the European Commission
showed consumer sentiment rose in April to the highest reading
since October 2007, indicating consumers in the currency-area are
becoming more willing to spend.
Earlier, Eurostat said construction in the euro zone grew 0.1%
in February, slowing from January's increase of 1.6%. Construction
in February expanded 6.7% from a year earlier.
More news from MarketWatch:
Manchester United fires manager David Moyes
Lack of upside catalysts weigh on gold
Subscribe to WSJ: http://online.wsj.com?mod=djnwires